[ { "scene_index": 1, "title": "The Allocation Scandal", "narration_text": "The Allocation Scandal.\n\nfifty-five million people die annually. The National Institutes of Health has an annual budget of", "context": "Introduction to the section title and the stark reality of global annual death rates.", "char_start": 0, "char_end": 121, "start_ms": 240, "end_ms": 8980, "duration_ms": 8740, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 2, "title": "NIH Annual Budget", "narration_text": " approximately FORTY-SEVEN BILLION DOLLARS. You would think those two facts would be related. They are not.", "context": "Contrasting the massive NIH budget with the lack of direct relationship to total annual deaths.", "char_start": 121, "char_end": 226, "start_ms": 8680, "end_ms": 16640, "duration_ms": 7960, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 3, "title": "Ten-Year Spending", "narration_text": "\n\nOf two hundred and forty-seven billion dollars the N.I.H. spent over a decade, exactly three point three percent", "context": "Breaking down the total decade-long spending of the NIH and the tiny percentage for human testing.", "char_start": 226, "char_end": 341, "start_ms": 16420, "end_ms": 25160, "duration_ms": 8740, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 4, "title": "Testing vs Everything Else", "narration_text": " went to testing whether treatments actually work in humans. The other ninety-six point seven percent went to everything else.", "context": "Highlighting the extreme disparity between actual treatment testing and all other budget uses.", "char_start": 341, "char_end": 466, "start_ms": 24640, "end_ms": 33440, "duration_ms": 8800, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 5, "title": "Safe Compound Defensible", "narration_text": "\n\nThat might be defensible if we'd already tested all the known safe compounds that are piled up waiting for human testing.", "context": "Explaining that the spending might be justified only if there weren't already waiting compounds.", "char_start": 466, "char_end": 589, "start_ms": 33160, "end_ms": 42320, "duration_ms": 9160, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 6, "title": "9,500 Safe Profiles", "narration_text": " We haven't.\n\nThere are roughly nine thousand five hundred compounds with established safety profiles, and ninety-nine point", "context": "Revealing the huge number of safe compounds that exist but remain largely ignored for clinical use.", "char_start": 589, "char_end": 713, "start_ms": 42000, "end_ms": 51740, "duration_ms": 9740, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 7, "title": "Overflowing Pipeline", "narration_text": " seven percent of their possible disease applications have never been tested.\n\nThe pipeline is overflowing with candidates.", "context": "Emphasizing that nearly all potential disease uses for existing safe drugs are untested.", "char_start": 713, "char_end": 834, "start_ms": 51440, "end_ms": 59740, "duration_ms": 8300, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 8, "title": "The Trial Bottleneck", "narration_text": " The bottleneck is trials.\n\nIt's like spending ninety-six point seven percent of your grocery budget on cookbooks and", "context": "Identifying clinical trials as the core problem and starting a household budget analogy.", "char_start": 834, "char_end": 951, "start_ms": 59640, "end_ms": 68320, "duration_ms": 8680, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 9, "title": "Cookbook vs Food", "narration_text": " three point three percent on food, then wondering why you're starving.\n\nThis isn't just inefficiency. It's a body count.", "context": "Finishing the analogy to show how skewed priorities lead to lethal consequences.", "char_start": 951, "char_end": 1072, "start_ms": 67800, "end_ms": 76820, "duration_ms": 9020, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 10, "title": "JAMA Spending Study", "narration_text": "\n\nA J.A.M.A. study broke down two hundred and forty-seven point three billion dollars in N.I.H. spending (twenty ten to twenty nineteen).", "context": "Introducing the academic data source that analyzed NIH spending over the previous decade.", "char_start": 1072, "char_end": 1209, "start_ms": 76720, "end_ms": 87440, "duration_ms": 10720, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 11, "title": "A Rational Ratio?", "narration_text": " Each of these categories funds valuable work. The question is whether the ratio makes sense when thousands of safe compounds sit untested.", "context": "Questioning if current funding ratios are logical given the volume of untested treatments.", "char_start": 1209, "char_end": 1347, "start_ms": 86700, "end_ms": 97540, "duration_ms": 10840, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 12, "title": "Basic Research Portion", "narration_text": "\n\nEighty-four point nine percent of the budget, or two hundred and nine point nine billion dollars, went to basic research like", "context": "Detailing the massive amount of funding allocated to fundamental laboratory research.", "char_start": 1347, "char_end": 1474, "start_ms": 96900, "end_ms": 105840, "duration_ms": 8940, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 13, "title": "Disease Mechanisms Focus", "narration_text": " understanding disease mechanisms, molecular biology, and genomics. This is essential for identifying new targets,", "context": "Explaining what basic research covers, such as identifying new molecular targets for disease.", "char_start": 1474, "char_end": 1588, "start_ms": 105320, "end_ms": 113980, "duration_ms": 8660, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 14, "title": "Understanding vs Testing", "narration_text": " but eighty-five cents of every dollar is a lot of understanding and not much testing.\n\nEleven point eight percent, totaling", "context": "Criticizing the focus on theory over practical application and introducing non-trial research.", "char_start": 1588, "char_end": 1713, "start_ms": 113420, "end_ms": 122980, "duration_ms": 9560, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 15, "title": "Non-Trial Applied Research", "narration_text": " twenty-nine point three billion dollars, was spent on non-trial applied research which translates discoveries toward practical use", "context": "Defining applied research that attempts to bridge the gap but still avoids clinical trials.", "char_start": 1713, "char_end": 1845, "start_ms": 122780, "end_ms": 130940, "duration_ms": 8160, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 16, "title": "Discovery Toward Practicality", "narration_text": " without the final step of testing them in patients.\n\nThe clinical and translational science awards, or C.T.S.A. infrastructure", "context": "Highlighting that this research stops before it reaches patients and introduces the CTSA program.", "char_start": 1845, "char_end": 1972, "start_ms": 131060, "end_ms": 140320, "duration_ms": 9260, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 17, "title": "CTSA Infrastructure", "narration_text": " program, uses about one billion dollars per year for trial infrastructure, coordination, and training.", "context": "Allocating costs for the administration and logistics of clinical trials.", "char_start": 1972, "char_end": 2076, "start_ms": 140320, "end_ms": 147360, "duration_ms": 7040, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 18, "title": "Observational Study Funding", "narration_text": "\n\nObservational studies for population health data collection, such as the All of Us program at two point one six billion dollars,", "context": "Describing large-scale data collection programs that watch health trends without testing interventions.", "char_start": 2076, "char_end": 2208, "start_ms": 147000, "end_ms": 155640, "duration_ms": 8640, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 19, "title": "Observation vs Intervention", "narration_text": " are valuable for identifying patterns, but observation without intervention doesn't cure anyone.\n\nOther applied research includes", "context": "Noting that while patterns are important, observation alone cannot provide a medical cure.", "char_start": 2208, "char_end": 2337, "start_ms": 156080, "end_ms": 164320, "duration_ms": 8240, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 20, "title": "Drug Characterization", "narration_text": " drug characterization, health services research, and epidemiology.\n\nOnly three point three percent, or eight point one billion dollars,", "context": "Listing miscellaneous research fields and returning to the tiny portion spent on actual trials.", "char_start": 2337, "char_end": 2473, "start_ms": 163800, "end_ms": 173500, "duration_ms": 9700, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 21, "title": "Phased Clinical Trials", "narration_text": " went to phased clinical trials, which is the only category that directly tests whether treatments work in humans (phases one to three).", "context": "Defining the specific types of clinical trials that are critical for verifying drug effectiveness.", "char_start": 2473, "char_end": 2610, "start_ms": 172920, "end_ms": 182240, "duration_ms": 9320, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 22, "title": "Phase One Funding", "narration_text": "\n\nPhase one received one point five billion dollars, which is eighteen point five percent of the clinical trial budget.", "context": "Breaking down the budget for Phase One, the earliest stage of human testing.", "char_start": 2610, "char_end": 2729, "start_ms": 183040, "end_ms": 189460, "duration_ms": 6420, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 23, "title": "Phase Two and Three", "narration_text": "\n\nPhase two received three point five billion dollars, or forty-three point two percent.\n\nPhase three received two point six billion", "context": "Moving through the funding for Phase Two and the start of Phase Three clinical stages.", "char_start": 2729, "char_end": 2861, "start_ms": 190060, "end_ms": 198700, "duration_ms": 8640, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 24, "title": "NIH Phase Three Stake", "narration_text": " dollars, or thirty-two point one percent, while the N.I.H. covers only three point seven to four point three percent of phase", "context": "Highlighting how little the NIH contributes to the most expensive stage of drug development.", "char_start": 2861, "char_end": 2987, "start_ms": 198220, "end_ms": 207140, "duration_ms": 8920, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 25, "title": "Industry Profit Potential", "narration_text": " three costs, leaving completion to industry, which only funds trials with patent-protected profit potential.", "context": "Explaining that the private sector only completes trials if there is a guaranteed high profit.", "char_start": 2987, "char_end": 3097, "start_ms": 207020, "end_ms": 214120, "duration_ms": 7100, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 26, "title": "Unclassified Overhead", "narration_text": "\n\nAbout five hundred million dollars, or six point two percent, went to other unclassified costs for cross-phase overhead,", "context": "Describing the miscellaneous pilot and cross-stage costs within the trial budget.", "char_start": 3097, "char_end": 3220, "start_ms": 214600, "end_ms": 222520, "duration_ms": 7920, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 27, "title": "Pragmatic Trial Efficiency", "narration_text": " pilot studies, and trials not classified to a single phase.\n\nPragmatic trials, which can be thirty times cheaper, remain", "context": "Mentioning the funding neglect for more efficient, low-cost pragmatic trial models.", "char_start": 3220, "char_end": 3342, "start_ms": 222980, "end_ms": 231940, "duration_ms": 8960, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 28, "title": "Why This Exists", "narration_text": " severely underfunded despite proven efficiency.\n\nWhy This Allocation Exists.\n\nThis isn't bureaucratic accident.", "context": "Beginning to explore the systemic and intentional reasons behind the budget structure.", "char_start": 3342, "char_end": 3454, "start_ms": 231180, "end_ms": 240960, "duration_ms": 9780, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 29, "title": "Taxpayer Absorbed Risk", "narration_text": " It's lobbied outcome.\n\nDrug companies love the N.I.H. Taxpayers absorb the risk of basic research; industry patents whatever works.", "context": "Describing the relationship between public funding of risky research and private patenting of results.", "char_start": 3454, "char_end": 3587, "start_ms": 240840, "end_ms": 250860, "duration_ms": 10020, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 30, "title": "The Kitchen Analogy", "narration_text": " It's like if your neighbor paid for your kitchen renovation, and then you charged them rent to eat there.\n\nBut independent trials", "context": "Using a housing analogy to illustrate the exploitation of public funds by private pharma.", "char_start": 3587, "char_end": 3717, "start_ms": 250720, "end_ms": 257940, "duration_ms": 7220, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 31, "title": "Terrifying Head-to-Head Trials", "narration_text": " comparing drugs head-to-head? Those are terrifying. They might reveal that the eighty thousand dollar drug works about as well", "context": "Explaining why the industry fears trials that compare expensive new drugs to cheap generics.", "char_start": 3717, "char_end": 3845, "start_ms": 257740, "end_ms": 264600, "duration_ms": 6860, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 32, "title": "Pharmaceutical Lobby Opposition", "narration_text": " as the four dollar generic. PhRMA, the pharmaceutical lobby, has consistently opposed comparative effectiveness research.", "context": "Identifying the PhRMA lobby's active role in preventing research that threatens their drug prices.", "char_start": 3845, "char_end": 3967, "start_ms": 264620, "end_ms": 272720, "duration_ms": 8100, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 33, "title": "PCORI and Lobbying", "narration_text": "When Congress created the Patient-Centered Outcomes Research Institute, or PCORI, in twenty ten, industry successfully lobbied to prohibit it", "context": "The narrator explains how industry interests influenced the creation and scope of PCORI.", "char_start": 7930, "char_end": 8071, "start_ms": 543400, "end_ms": 554820, "duration_ms": 11420, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 34, "title": "Laws Against Savings", "narration_text": " from making coverage recommendations based on cost-effectiveness. Congress literally passed a law saying \"don't fund research that might lower drug prices.\"", "context": "Legislative restrictions were put in place to ensure drug prices wouldn't be threatened by new research.", "char_start": 8071, "char_end": 8227, "start_ms": 554900, "end_ms": 565720, "duration_ms": 10820, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 35, "title": "The Revolving Door", "narration_text": " They wrote it down. In legislation. On purpose. The revolving door helps. N.I.H. advisory committees include industry representatives.", "context": "The narrator describes the systemic way industry and the NIH are intertwined.", "char_start": 8227, "char_end": 8362, "start_ms": 565420, "end_ms": 575980, "duration_ms": 10560, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 36, "title": "Misaligned Incentives", "narration_text": " Former N.I.H. officials join pharmaceutical boards. Academic researchers depend on industry grants. Everyone's incentives align against cheap,", "context": "A look at how financial and professional incentives discourage the testing of low-cost medical alternatives.", "char_start": 8362, "char_end": 8505, "start_ms": 575980, "end_ms": 586540, "duration_ms": 10560, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 37, "title": "Avoiding Cheap Drug Tests", "narration_text": " fast trials testing whether expensive drugs outperform generics. It's not a conspiracy. It's just that everyone involved happens to benefit from", "context": "The system naturally avoids trials that might favor cheap generic drugs over high-profit ones.", "char_start": 8505, "char_end": 8651, "start_ms": 586160, "end_ms": 596060, "duration_ms": 9900, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 38, "title": "The Publication Cycle", "narration_text": " the same terrible outcome, purely by coincidence, repeatedly, for decades. Basic research produces publications. Publications produce tenure.", "context": "The focus on academic advancement through papers rather than patient outcomes is highlighted.", "char_start": 8651, "char_end": 8794, "start_ms": 595700, "end_ms": 606280, "duration_ms": 10580, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 39, "title": "Need for Papers", "narration_text": " Tenure produces more grants. Nobody in this cycle needs anyone to get better. They need papers. The three point three percent allocation isn't a mystery.", "context": "Narrator emphasizes that the medical research system prioritizes data and grants over actual healing.", "char_start": 8794, "char_end": 8948, "start_ms": 605620, "end_ms": 616000, "duration_ms": 10380, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 40, "title": "Efficiency Gap Intro", "narration_text": " It's a business model. The Efficiency Gap: A Tale of Two Trials. The difference between efficient and inefficient trial design isn't theoretical.", "context": "Transitioning to a real-world comparison of trial designs during the COVID-19 pandemic.", "char_start": 8948, "char_end": 9094, "start_ms": 615820, "end_ms": 624360, "duration_ms": 8540, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 41, "title": "COVID Trial Comparison", "narration_text": " Humanity accidentally ran a controlled experiment on itself during COVID. Two countries. Same disease. One spent like it was trying to cure death.", "context": "Setting the stage for the comparison between the US and UK approaches to COVID trials.", "char_start": 9094, "char_end": 9241, "start_ms": 624120, "end_ms": 635280, "duration_ms": 11160, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 42, "title": "RECOVER Initiative Budget", "narration_text": " The other actually did. RECOVER Initiative (N.I.H. Approach). Budget: one point six six five billion dollars (one point one five billion dollars", "context": "Introduction to the massive budget allocated to the NIH's RECOVER initiative.", "char_start": 9241, "char_end": 9387, "start_ms": 635060, "end_ms": 645440, "duration_ms": 10380, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 43, "title": "RECOVER Sluggish Pace", "narration_text": " plus five hundred and fifteen million dollars in twenty twenty-four) (source). Timeline: four years and counting. Patients enrolled: approximately", "context": "Detailing the slow progress and massive spending of the RECOVER initiative over four years.", "char_start": 9387, "char_end": 9536, "start_ms": 644980, "end_ms": 656560, "duration_ms": 11580, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 44, "title": "RECOVER High Costs", "narration_text": " thirty thousand. Trials completed: Zero. Cost per patient: fifty-five thousand five hundred dollars. RECOVERY Trial (U.K. Approach).", "context": "Contrasting the high cost and zero completion rate of the NIH trial with the UK model.", "char_start": 9536, "char_end": 9669, "start_ms": 656560, "end_ms": 666400, "duration_ms": 9840, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 45, "title": "UK RECOVERY Success", "narration_text": " Budget: twenty million dollars. Timeline: six months. Patients enrolled: forty-eight thousand. Treatments found: Multiple, including dexamethasone", "context": "Describing the efficiency and success of the UK’s RECOVERY trial.", "char_start": 9669, "char_end": 9817, "start_ms": 666140, "end_ms": 675000, "duration_ms": 8860, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 46, "title": "Cost Comparison", "narration_text": " (saved over one million lives). Cost per patient: five hundred dollars. The N.I.H. spent one hundred and eleven times more per patient and achieved", "context": "The narrator points out the vast disparity in cost-effectiveness between the US and UK trials.", "char_start": 9817, "char_end": 9966, "start_ms": 675000, "end_ms": 685940, "duration_ms": 10940, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 47, "title": "Infinite Gap", "narration_text": " infinitely less (dividing by zero trials completed produces infinity, which is fitting because that's how long patients waited). This efficiency gap", "context": "The narrator notes that with zero trials completed, the NIH's performance is effectively infinitely worse.", "char_start": 9966, "char_end": 10118, "start_ms": 685280, "end_ms": 696300, "duration_ms": 11020, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 48, "title": "Pragmatic Trial Median", "narration_text": " is not unique to RECOVERY. A systematic review of sixty-four pragmatic trials found a median cost of ninety-seven dollars per patient.", "context": "Evidence is provided that clinical trials can be done far more cheaply than the NIH usually does them.", "char_start": 10118, "char_end": 10254, "start_ms": 696220, "end_ms": 706780, "duration_ms": 10560, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 49, "title": "Dinner vs SUV", "narration_text": " The British cured disease for the price of a nice dinner per patient. America spent the price of a luxury SUV per patient and cured nothing.", "context": "A stark visual comparison of the spending habits of the two nations' medical research departments.", "char_start": 10254, "char_end": 10396, "start_ms": 706220, "end_ms": 716960, "duration_ms": 10740, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 50, "title": "Capability vs Addiction", "narration_text": " The problem isn't that curing disease is hard. The N.I.H. doesn't have a capability problem. It has a shopping addiction.", "context": "The narrator argues the issue is spending habits, not a lack of scientific ability.", "char_start": 10396, "char_end": 10517, "start_ms": 716960, "end_ms": 724640, "duration_ms": 7680, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 51, "title": "Budget Misallocation", "narration_text": " The Death Toll: Opportunity Cost of Misallocation. When you misallocate the vast majority of a forty-seven billion dollar annual budget into", "context": "Introducing the lethal consequences of wasting the NIH budget on inefficient research.", "char_start": 10517, "char_end": 10658, "start_ms": 724900, "end_ms": 733460, "duration_ms": 8560, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 52, "title": "Composting People", "narration_text": " low-efficiency research instead of high-efficiency clinical trials, you aren't just wasting money. You are composting people.", "context": "A metaphorical description of the human lives lost due to bureaucratic waste.", "char_start": 10658, "char_end": 10784, "start_ms": 733460, "end_ms": 741660, "duration_ms": 8200, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 53, "title": "Cost Per QALY", "narration_text": " Cost Per Q.A.L.Y. (Quality-Adjusted Life Year). Standard N.I.H. Portfolio: fifty thousand dollars per Q.A.L.Y. at standard medical research R.O.I.", "context": "Technical comparison of the ROI of standard NIH research using the QALY metric.", "char_start": 10784, "char_end": 10931, "start_ms": 741460, "end_ms": 752720, "duration_ms": 11260, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 54, "title": "ROI Comparison", "narration_text": " (and that's being generous). Pragmatic Platform Trials: four dollars per Q.A.L.Y. Every one dollar spent on efficient pragmatic trials buys", "context": "Highlighting the massive increase in health value when using pragmatic trials instead of current methods.", "char_start": 10931, "char_end": 11072, "start_ms": 752060, "end_ms": 762840, "duration_ms": 10780, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 55, "title": "ADAPTABLE Proof", "narration_text": " twelve thousand five hundred times more health than a dollar spent on the current N.I.H. portfolio. The ADAPTABLE trial proved pragmatic trials", "context": "Statistical proof from the ADAPTABLE trial regarding the superiority of pragmatic trial costs.", "char_start": 11072, "char_end": 11217, "start_ms": 762840, "end_ms": 774040, "duration_ms": 11200, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 56, "title": "Trial Cost Science", "narration_text": " cost thirty times less than traditional R.C.T.s (fourteen million dollars versus four hundred and twenty million dollars). Same science.", "context": "Showing that the science is identical, but the price tag is dramatically different.", "char_start": 11217, "char_end": 11354, "start_ms": 773500, "end_ms": 782950, "duration_ms": 9450, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 57, "title": "Death Equivalent Intro", "narration_text": " Fewer catered meetings. The \"Death Equivalent\" of Budget Misallocation. The annual opportunity cost is approximately one hundred million", "context": "Calculating the total human cost of not using more efficient trial methods.", "char_start": 11354, "char_end": 11493, "start_ms": 783320, "end_ms": 793380, "duration_ms": 10060, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 58, "title": "Seven Million Deaths", "narration_text": " quality-adjusted life years, or Q.A.L.Y.s, and about seven million death-equivalents per year.", "context": "Providing a staggering statistic of potential lives lost due to budget mismanagement.", "char_start": 11493, "char_end": 11588, "start_ms": 792800, "end_ms": 800420, "duration_ms": 7620, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 59, "title": "Conservative Death Estimate", "narration_text": " Even the most conservative estimate is approximately ten million Q.A.L.Y.s and seven hundred thousand preventable deaths annually.", "context": "The narrator concludes with the most cautious, yet still tragic, estimate of annual preventable deaths.", "char_start": 11588, "char_end": 11721, "start_ms": 799660, "end_ms": 810040, "duration_ms": 10380, "timestamp_source": "alignment", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 60, "title": "NIH Cost Disparity", "narration_text": "For every dollar spent on pragmatic trials producing Q.A.L.Y.s, the N.I.H. spends twelve thousand five hundred dollars to achieve the same result.", "context": "Comparing the cost efficiency of pragmatic trials versus standard NIH spending.", "char_start": 15544, "char_end": 15691, "start_ms": 584836, "end_ms": 590367, "duration_ms": 5531, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 61, "title": "Potential Capacity", "narration_text": " You are operating at zero point zero zero eight percent of your potential capacity to save lives.", "context": "Highlighting the massive inefficiency in current life-saving potential.", "char_start": 15691, "char_end": 15789, "start_ms": 590367, "end_ms": 594054, "duration_ms": 3687, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 62, "title": "Car Efficiency Analogy", "narration_text": " If your car ran at zero point zero zero eight percent efficiency, it would move one inch per gallon.", "context": "An analogy comparing medical research efficiency to a car's fuel economy.", "char_start": 15789, "char_end": 15891, "start_ms": 594054, "end_ms": 597892, "duration_ms": 3838, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 63, "title": "Heart Function Analogy", "narration_text": "\n\nIf your heart pumped at zero point zero zero eight percent efficiency, you'd be dead before finishing this sentence.", "context": "An analogy comparing research efficiency to a failing human heart.", "char_start": 15891, "char_end": 16009, "start_ms": 597892, "end_ms": 602331, "duration_ms": 4439, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 64, "title": "Rewarding Inefficiency", "narration_text": " Your medical research system runs at zero point zero zero eight percent efficiency, and you gave it a raise.", "context": "Criticizing the decision to increase funding for an inefficient system.", "char_start": 16009, "char_end": 16119, "start_ms": 602331, "end_ms": 606470, "duration_ms": 4139, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 65, "title": "The Translation Crisis", "narration_text": "\n\nThe Translation Crisis: All Theory, No Medicine.\n\nThe problem is not a shortage of ideas. It is a shortage of anyone bothering to test them.", "context": "Defining the 'Translation Crisis' as a lack of clinical testing rather than ideas.", "char_start": 16119, "char_end": 16263, "start_ms": 606470, "end_ms": 611888, "duration_ms": 5418, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 66, "title": "Safe Human Drugs", "narration_text": "\n\nThere are over twenty thousand F.D.A. approved drugs known to be safe in humans. There are between forty-seven hundred", "context": "Mentioning the 20,000 FDA-approved drugs that are safe for use and the potential for repurposing.", "char_start": 16263, "char_end": 16383, "start_ms": 611888, "end_ms": 616403, "duration_ms": 4515, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 67, "title": "Repurposable Compounds", "narration_text": " and sixty-eight hundred repurposable compounds, which are clinically-tested candidates (including three thousand four hundred", "context": "Describing thousands of clinical candidates that remain untested despite their safety profile.", "char_start": 16383, "char_end": 16507, "start_ms": 616403, "end_ms": 621068, "duration_ms": 4665, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 68, "title": "Dementia Interventions", "narration_text": " and twenty-two marketed drugs) gathering dust.\n\nThere are hundreds of plausible dementia interventions.", "context": "Highlighting the surplus of untested dementia treatment ideas that are currently ignored.", "char_start": 16507, "char_end": 16610, "start_ms": 621068, "end_ms": 624944, "duration_ms": 3876, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 69, "title": "Local Trial Scarcity", "narration_text": "\n\nThe number of clinical trials available for your grandma in Saint Louis is zero. You have a warehouse of safe molecules", "context": "The lack of actual clinical trials available for patients in need despite the surplus of drugs.", "char_start": 16610, "char_end": 16733, "start_ms": 624944, "end_ms": 629571, "duration_ms": 4627, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 70, "title": "Testing Facility Closed", "narration_text": " that have never been systematically tested for new uses. The warehouse is full. The testing facility is closed for a team-building retreat.", "context": "An analogy for the lack of systematic testing despite available molecules.", "char_start": 16733, "char_end": 16874, "start_ms": 629571, "end_ms": 634876, "duration_ms": 5305, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 71, "title": "Publishing House Metric", "narration_text": "\n\nThe N.I.H. is, by its own metrics, a publishing house that occasionally dabbles in medicine:", "context": "Characterizing the NIH as more of a publisher than a medical institution.", "char_start": 16874, "char_end": 16970, "start_ms": 634876, "end_ms": 638488, "duration_ms": 3612, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 72, "title": "Paper Production", "narration_text": "\n\nTwo point five million N.I.H. funded papers are published annually. About fifty new treatments are approved annually.", "context": "The massive volume of NIH-funded papers compared to the tiny number of actual treatments.", "char_start": 16970, "char_end": 17088, "start_ms": 638488, "end_ms": 642928, "duration_ms": 4440, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 73, "title": "Conversion Failure", "narration_text": "\n\nThe conversion rate from paper to patient is zero point zero zero two percent. For every fifty thousand papers, one drug reaches a human.", "context": "The extremely low success rate of turning academic papers into approved drugs.", "char_start": 17088, "char_end": 17229, "start_ms": 642928, "end_ms": 648233, "duration_ms": 5305, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 74, "title": "Citation Loop", "narration_text": " The rest become citations in other papers, which become citations in other papers, in an infinite loop of academics reading each other's homework.", "context": "Describing the self-referential nature of academic publishing.", "char_start": 17229, "char_end": 17376, "start_ms": 648233, "end_ms": 653764, "duration_ms": 5531, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 75, "title": "Low Participation", "narration_text": "\n\nPlenty of Knowledge. No Translation.\n\nAbout five percent of patients have participated in trials.", "context": "Statistics on the small number of patients currently participating in clinical trials.", "char_start": 17376, "char_end": 17474, "start_ms": 653764, "end_ms": 657451, "duration_ms": 3687, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 76, "title": "Invitation Gap", "narration_text": "\n\nAbout fifty percent of patients are willing to participate if invited. Only nine to eleven percent of patients are actually invited.", "context": "The massive gap between patient willingness and the actual invitations to join trials.", "char_start": 17474, "char_end": 17608, "start_ms": 657451, "end_ms": 662493, "duration_ms": 5042, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 77, "title": "Asking the Question", "narration_text": "\n\nHalf of all patients would join a clinical trial if asked. Almost nobody asks. It's like having a room full of volunteers and a clipboard,", "context": "Most patients would join trials if they were simply asked, but the system focuses on theory.", "char_start": 17608, "char_end": 17750, "start_ms": 662493, "end_ms": 667836, "duration_ms": 5343, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 78, "title": "Understanding vs Curing", "narration_text": " and choosing to study the clipboard.\n\nUnderstanding disease and curing disease are completely different activities.", "context": "Distinguishing between the academic study of disease and its actual clinical cure.", "char_start": 17750, "char_end": 17865, "start_ms": 667836, "end_ms": 672162, "duration_ms": 4326, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 79, "title": "Microscope Choice", "narration_text": " One requires microscopes. The other requires giving people medicine and seeing if they stop dying. The N.I.H. chose microscopes.", "context": "The NIH's institutional preference for microscopic study over direct clinical application.", "char_start": 17865, "char_end": 17994, "start_ms": 672162, "end_ms": 677016, "duration_ms": 4854, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 80, "title": "The Club Goods Scam", "narration_text": "\n\nThe Public Goods versus Club Goods Scam.\n\nThe N.I.H. claims to produce \"public goods\" like open science and training.", "context": "Introducing the argument that NIH research serves private industry interests over public benefit.", "char_start": 17994, "char_end": 18116, "start_ms": 677016, "end_ms": 681606, "duration_ms": 4590, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 81, "title": "Pharma Subsidy", "narration_text": " What it actually produces is a free R. and D. department for pharmaceutical companies, funded by the same people who then pay full price for the drugs.", "context": "Explaining how taxpayers fund research that private drug companies then profit from.", "char_start": 18116, "char_end": 18268, "start_ms": 681606, "end_ms": 687325, "duration_ms": 5719, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 82, "title": "Taxpayer Funded Research", "narration_text": "\n\nTaxpayers funded research behind ninety-nine percent of new drugs (three hundred and fifty-six drugs, twenty ten to twenty nineteen).", "context": "Statistics showing that nearly all new drugs are rooted in research paid for by the public.", "char_start": 18268, "char_end": 18403, "start_ms": 687325, "end_ms": 692404, "duration_ms": 5079, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 83, "title": "Socialized Loss", "narration_text": " Industry patents the winners. The public pays again through high drug prices. When research leads to a dead end, the public eats the loss.", "context": "The public bears the financial risk of research failures while private companies keep the profits.", "char_start": 18403, "char_end": 18543, "start_ms": 692404, "end_ms": 697672, "duration_ms": 5268, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 84, "title": "NIH Mission", "narration_text": " You pay for the lottery ticket. They cash the winnings.\n\nThe only things the N.I.H. *should* fund are things private companies *cannot* profitably fund:", "context": "Identifying what the NIH should focus on: areas where private industry has no financial incentive.", "char_start": 18543, "char_end": 18694, "start_ms": 697672, "end_ms": 703353, "duration_ms": 5681, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 85, "title": "Pragmatic Platforms", "narration_text": "\n\nOpen pragmatic trial platforms: thirty times cheaper than traditional trials, yet receive minimal N.I.H. funding.", "context": "Open trial platforms are significantly cheaper and more effective but remain underfunded.", "char_start": 18694, "char_end": 18807, "start_ms": 703353, "end_ms": 707605, "duration_ms": 4252, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 86, "title": "Profitless Generics", "narration_text": "\n\nRe-purposing generic drugs: more than four thousand seven hundred clinically-tested compounds where no patent equals no profit equals no interest.", "context": "The industry's lack of interest in repurposing drugs that are no longer under patent protection.", "char_start": 18807, "char_end": 18955, "start_ms": 707605, "end_ms": 713173, "duration_ms": 5568, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 87, "title": "Comparative Data", "narration_text": "\n\nComparative effectiveness data: Head-to-head trials revealing which drugs actually work best (pharma's nightmare).", "context": "The need for trials that directly compare the effectiveness of different medications.", "char_start": 18955, "char_end": 19069, "start_ms": 713173, "end_ms": 717462, "duration_ms": 4289, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 88, "title": "Avoiding Competition", "narration_text": "\n\nThese are the *only* things the N.I.H. should be funding. Instead, the N.I.H. explicitly avoids them to \"not crowd out industry.\"", "context": "The NIH's policy of avoiding research that might interfere with private industry profits.", "char_start": 19069, "char_end": 19202, "start_ms": 717462, "end_ms": 722466, "duration_ms": 5004, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 89, "title": "Lowering Prices", "narration_text": " Translation: \"We won't run the trials that would lower drug prices, because the people who set drug prices asked us nicely.\".", "context": "Criticizing the NIH's refusal to perform research that could lead to lower drug costs.", "char_start": 19202, "char_end": 19329, "start_ms": 722466, "end_ms": 727245, "duration_ms": 4779, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 90, "title": "Outcome Disconnect", "narration_text": "\n\nThe Patient Disconnect: Zero Correlation with Health Outcomes.", "context": "Summarizing the lack of alignment between NIH research and actual patient health.", "char_start": 19329, "char_end": 19394, "start_ms": 727245, "end_ms": 729690, "duration_ms": 2445, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 91, "title": "Funding Burden", "narration_text": "\n\nCorrelation between N.I.H. funding priorities and actual disease burden: zero point zero seven.", "context": "Final statistic showing near-zero correlation between funding and the actual impact of diseases.", "char_start": 19394, "char_end": 19494, "start_ms": 729690, "end_ms": 733453, "duration_ms": 3763, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 92, "title": "Coin Flip Science", "narration_text": "That is not a typo. On a scale of zero (random) to one (perfect), the N.I.H. scores \"basically a coin flip.\"", "context": "The author critiques the N.I.H. research funding allocation, comparing its effectiveness to a coin toss.", "char_start": 23432, "char_end": 23540, "start_ms": 881618, "end_ms": 885682, "duration_ms": 4064, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 93, "title": "Patient Desires", "narration_text": " A dartboard would allocate research funding more rationally.\n\nWhat patients want.\n\nMedicine that works.\n\n", "context": "Contrasting the irrationality of current funding with the fundamental needs of patients.", "char_start": 23540, "char_end": 23646, "start_ms": 885682, "end_ms": 889670, "duration_ms": 3988, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 94, "title": "Access and Cures", "narration_text": "Access to experimental therapies.\n\nTrials they can join.\n\nA cure before they die.\n\nWhat N.I.H. funds.\n\n", "context": "Listing specific patient goals versus what the N.I.H. actually chooses to finance.", "char_start": 23646, "char_end": 23750, "start_ms": 889670, "end_ms": 893583, "duration_ms": 3913, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 95, "title": "Institutional Goals", "narration_text": "Molecular mechanisms.\n\nPapers in prestigious journals.\n\nResearch empires.\n\nInstitutional overhead.\n\n", "context": "Describing the academic and bureaucratic outcomes that the N.I.H. prioritizes over cures.", "char_start": 23750, "char_end": 23850, "start_ms": 893583, "end_ms": 897345, "duration_ms": 3762, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 96, "title": "The Logic of Committees", "narration_text": "Patients don't control the money. Committees do. And committees optimize for the continued existence of committees. ", "context": "Explaining how the structure of funding bodies leads to institutional self-preservation.", "char_start": 23850, "char_end": 23965, "start_ms": 897345, "end_ms": 901672, "duration_ms": 4327, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 97, "title": "Bureaucratic Nature", "narration_text": "This is true of all committees, everywhere, since the invention of committees. Nobody has ever convened a committee ", "context": "Discussing the inherent nature of bureaucracy and its tendency to expand rather than shrink.", "char_start": 23965, "char_end": 24080, "start_ms": 901672, "end_ms": 905999, "duration_ms": 4327, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 98, "title": "The Trillion Dollar Track Record", "narration_text": "that recommended fewer committees.\n\nThe Track Record.\n\nSince nineteen seventy, the N.I.H. has spent over one point ", "context": "Transitioning to the long-term financial performance and historical output of the N.I.H.", "char_start": 24080, "char_end": 24194, "start_ms": 905999, "end_ms": 910288, "duration_ms": 4289, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 99, "title": "Zero Eradications", "narration_text": "one trillion dollars (inflation-adjusted). Diseases eradicated: Zero.\n\nThis isn't because eradicating disease is ", "context": "Starkly noting that despite a trillion dollars in spending, no human diseases have been wiped out.", "char_start": 24194, "char_end": 24313, "start_ms": 910288, "end_ms": 914766, "duration_ms": 4478, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 100, "title": "Smallpox and Polio", "narration_text": "impossible:\n\nThe W.H.O. eradicated smallpox for three hundred million dollars.\n\nJonas Salk developed the polio ", "context": "Providing examples of major medical successes achieved outside the current N.I.H. framework.", "char_start": 24313, "char_end": 24426, "start_ms": 914766, "end_ms": 919017, "duration_ms": 4251, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 101, "title": "The Salk Exception", "narration_text": "vaccine in a university lab and gave it away for free (which is why nobody at the N.I.H. talks about him at parties).", "context": "Citing Jonas Salk's vaccine as a model of success that doesn't fit the N.I.H.'s institutional overhead model.", "char_start": 24426, "char_end": 24553, "start_ms": 919017, "end_ms": 923796, "duration_ms": 4779, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 102, "title": "Veterinary Successes", "narration_text": "\n\nVeterinarians have eradicated multiple animal diseases while the N.I.H. was forming subcommittees about forming ", "context": "Comparing the efficiency of animal medicine to the bureaucratic delays in human medicine.", "char_start": 24553, "char_end": 24669, "start_ms": 923796, "end_ms": 928160, "duration_ms": 4364, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 103, "title": "Better Outcomes for Cows", "narration_text": "subcommittees.\n\nCows have better healthcare outcomes than you do.\n\nWhat Would Actually Work.\n\nThe U.K. RECOVERY ", "context": "Concluding the critique of the N.I.H. and introducing a functional alternative trial model.", "char_start": 24669, "char_end": 24788, "start_ms": 928160, "end_ms": 932637, "duration_ms": 4477, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 104, "title": "The RECOVERY Trial", "narration_text": "trial already proved it. five hundred dollars per patient instead of forty-one thousand dollars. ", "context": "Showing the massive cost-efficiency of the U.K.'s pandemic trial versus American spending.", "char_start": 24788, "char_end": 24891, "start_ms": 932637, "end_ms": 936513, "duration_ms": 3876, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 105, "title": "Rapid Life-Saving Results", "narration_text": "First life-saving result in under one hundred days. Over one million lives saved. The blueprint exists. ", "context": "Detailing the tangible success of the RECOVERY trial in terms of speed and lives saved.", "char_start": 24891, "char_end": 25001, "start_ms": 936513, "end_ms": 940651, "duration_ms": 4138, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 106, "title": "The Blueprint for Success", "narration_text": "It is not theoretical. It happened. In England. During a pandemic. While Americans were arguing about horse dewormer.", "context": "Stressing that a successful research model already exists and was proven effective recently.", "char_start": 25001, "char_end": 25115, "start_ms": 940651, "end_ms": 944941, "duration_ms": 4290, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 107, "title": "Radical Recipe for Results", "narration_text": "\n\nThe recipe:\n\none. Pay for results: Treatment equals payment. No treatment equals no payment. Radical, I know.\n\n", "context": "Laying out the first step of a new research model: incentivizing results rather than processes.", "char_start": 25115, "char_end": 25234, "start_ms": 944941, "end_ms": 949418, "duration_ms": 4477, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 108, "title": "Open Science", "narration_text": "two. Publish everything: Including failures (especially failures).\n\nthree. Eliminate gatekeepers: Let patients ", "context": "Proposing transparency and the removal of bureaucratic barriers to patient participation.", "char_start": 25234, "char_end": 25345, "start_ms": 949418, "end_ms": 953594, "duration_ms": 4176, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } }, { "scene_index": 109, "title": "Automating Trust", "narration_text": "vote with participation.\n\nfour. Automate administration: Smart contracts instead of committees (committees cannot be trusted; see above).", "context": "Concluding with the idea of replacing fallible human committees with automated, transparent systems.", "char_start": 25345, "char_end": 25488, "start_ms": 953594, "end_ms": 958975, "duration_ms": 5381, "timestamp_source": "interpolation", "_auto_generated": { "keyframe_prompt": "", "veo_prompt": "" } } ]